Fused pentacyclic polyethers

Details Fused pentacyclic polyethers Fused pentacyclic polyethers

2007-04-10

2009-12-29

Seaman, D. Margaret (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S050000, C514S394000, C514S450000, C514S378000

Reexamination Certificate

active

07638500

ABSTRACT:
Disclosed are polycyclic polyether compounds of formula I and pharmaceutical compositions comprising such compounds.wherein R, OR1, and R2are as defined herein.Also disclosed are methods of regulating mucus clearance in a cell, and methods of treating decreased mucus clearance or mucociliary dysfunction.

REFERENCES:
Craig et al., Current Pharmaceutical Design 7, pp. 199-212.
Kuipers et al., Vaccines 23, pp. 4577-4588.
Conn et al., Inhalation Toxicology 12, pp. 783-827.
Abraham et al., “Airway Responses to Aerosolized Brevetoxins in an Animal Model of Asthma”, Am. J. Respir. Crit. Care Med., vol. 171, 26-34 (2005).
Boucher, R. C., “An overview of the Pathogenesis of Cystic Fibrosis Lung Disease”, Adv. Drug. Del. Rev., vol. 54, 1359-1371 (2002).
Boucher, R.C., “Relationship of Airway Epithelial Ion Transport to Chronic Bronchitis”, Proc. Am. Thorac. Soc., vol. 1, 66-70 (2004).
Hirsh, A. J., “Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents”, Adv. Drug Deliv. Rev., vol. 54, 1445-1462 (2002).

Affiliated with

Also associated with

Rating

Fused pentacyclic polyethers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused pentacyclic polyethers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused pentacyclic polyethers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4124691